Fig. 5From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties3D and 2D docking interaction of compound 7e with CDK2 in compered to the slandered STU299Back to article page